|
|
Line 6: |
Line 6: |
| !scope="col" style="padding:.4em" | Presenter | | !scope="col" style="padding:.4em" | Presenter |
| !scope="col" style="padding:.4em" | Paper title | | !scope="col" style="padding:.4em" | Paper title |
| + | |- |
| + | |style="padding:.4em;" rowspan=1|2016/8/22 |
| + | |style="padding:.4em;"|2016-18 |
| + | |style="padding:.4em;"DS Bae |
| + | |style="padding:.4em;text-align:left"| |
| + | [http://www.ncbi.nlm.nih.gov/pubmed/27264179 A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors] |
| + | |- |
| + | |style="padding:.4em;" rowspan=1|2016/8/8 |
| + | |style="padding:.4em;"|2016-17 |
| + | |style="padding:.4em;"EB Kim |
| + | |style="padding:.4em;text-align:left"| |
| + | [http://www.ncbi.nlm.nih.gov/pubmed/27064255 Enhancer-promoter interactions are encoded by complex genomic signatures on looping chromatin] |
| + | |- |
| + | |style="padding:.4em;" rowspan=1|2016/8/1 |
| + | |style="padding:.4em;"|2016-16 |
| + | |style="padding:.4em;"JW Cho |
| + | |style="padding:.4em;text-align:left"| |
| + | [http://www.ncbi.nlm.nih.gov/pubmed/27309802 The landscape of accessible chromatin in mammalian preimplantation embryos] |
| + | |- |
| + | |style="padding:.4em;" rowspan=1|2016/7/25 |
| + | |style="padding:.4em;"|2016-15 |
| + | |style="padding:.4em;"MY Lee |
| + | |style="padding:.4em;text-align:left"| |
| + | [http://www.ncbi.nlm.nih.gov/pubmed/27259156 Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients] |
| |- | | |- |
| |style="padding:.4em;" rowspan=1|2016/7/18 | | |style="padding:.4em;" rowspan=1|2016/7/18 |
− | |style="padding:.4em;"|2016-13 | + | |style="padding:.4em;"|2016-14 |
| |style="padding:.4em;"|CY Kim | | |style="padding:.4em;"|CY Kim |
| |style="padding:.4em;text-align:left"| | | |style="padding:.4em;text-align:left"| |
Date
|
Paper index
|
Paper title
|
2013/01/11
|
2012-81
|
(TH Kim) MuSiC: identifying mutational significance in cancer genomes.
|
2012/12/04
|
2012-80
|
(CY KIM) Human genomic disease variants: A neutral evolutionary explanation
|
2012/11/20
|
2012-79
|
(HS Shim) Circuitry and Dynamics of Human Transcription Factor Regulatory Networks
|
2012-78
|
(HJ Kim) Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins
|
2012/11/06
|
2012-77
|
(HJ Han) Systematic Localization of Common Disease-Associated Variation in Regulatory DNA
|
2012-76
|
(KS Kim) A public resource facilitating clinical use of genomes
|
2012/07/19
|
2012-75
|
(HJ Han & YH Ko) Predictive regulatory models in Drosophila melanogaster by integrative inference of transcriptional networks
|
2012-74
|
(JE Shim) An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People
|
2012-73
|
(JE Shim) Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes
|
2012-72
|
(SH Hwang) Network-based classification of breast cancer metastasis
|
2012-71
|
(T Lee&CY Kim)Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants
|
2012-70
|
(ER Kim&TH Kim)The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
|
2012/07/16
|
2012-69
|
(ER Kim&TH Kim)A framework for variation discovery and genotyping using next-generation DNA sequencing data
|
2012-66
|
(ER Kim&TH Kim)The Sequence Alignment/Map format and SAMtools
|
2012-65
|
(ER Kim&TH Kim)The Variant Call Format and VCFtools
|
2012-64
|
(YH Go&HJ Han)The Impact of the Gut Microbiota on Human Health: An Integrative View
|
2012-63
|
(T Lee&CY Kim)Host-Gut Microbiota Metabolic Interactions
|
2012-62
|
(AR Cho,JH Ju)Interactions Between the Microbiota and the Immune System
|
2012-61
|
(SH Hwang&HJ Cho)The Application of Ecological Theory Toward an Understanding of the Human Microbiome
|
2012-60
|
(SH Hwang&HJ Cho)Microbiota-Targeted Therapies: An Ecological Perspective
|
2012/07/13
|
2012-59
|
(JH Shin&HJ Kim)Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome
|
2012-58
|
(JH Shin&HJ Kim)A framework for human microbiome research
|
2012-57
|
(JH Shin&HJ Kim)Structure, function and diversity of the healthy human microbiome
|
2012/07/12
|
2012-56
|
(AR Cho&JH Ju)COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines
|
2012-55
|
(YH Go&HJ Han)Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
|
2012-54
|
(YH Go&HJ Han)A pharmacogenomic method for individualized prediction of drug sensitivity
|
2012-53
|
(JH Soh)The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
|
2012/07/09
|
2012-52
|
(ER Kim&TH Kim)The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|
2012-51
|
(ER Kim&TH Kim)Systematic identification of genomic markers of drug sensitivity in cancer cells
|
2012-50
|
(ER Kim&TH Kim)Subtype and pathway specific responses to anticancer compounds in breast cancer
|
2012-49
|
(JE Shim&KS Kim)De novo mutations revealed by whole-exome sequencing are strongly associated with autism
|
2012-48
|
(JE Shim&KS Kim)Patterns and rates of exonic de novo mutations in autism spectrum disorders
|
2012-47
|
(JE Shim&KS Kim)Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
|
2012/07/06
|
2012-46
|
(T Lee&CY Kim)Integrating Rare-Variant Testing, Function Prediction, and Gene Network in Composite Resequencing-Based Genome-Wide Association Studies (CR-GWAS)
|
2012-45
|
(T Lee&CY Kim)Type 2 Diabetes Risk Alleles Demonstrate Extreme Directional Differentiation among Human Populations, Compared to Other Diseases
|
2012-44
|
(AR Cho&JH Ju)Predicting mutation outcome from early stochastic variation in genetic interaction partners
|
2012-43
|
(AR Cho&JH Ju)Fitness Trade-Offs and Environmentally Induced Mutation Buffering in Isogenic C. elegans
|
2012-42
|
(JE Shim&KS Kim)Identification of microRNA-regulated gene networks by expression analysis of target genes
|
2012-41
|
(JE Shim&KS Kim)Exome sequencing and the genetic basis of complex traits
|
2012/07/02
|
2012-40
|
(JH Soh)Functional Repurposing Revealed by Comparing S. pombe and S. cerevisiae Genetic Interactions
|
2012-39
|
(ER Kim&TH Kim)De novo discovery of mutated driver pathways in cancer
|
2012-38
|
(YH Go&HJ Han)A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas
|
2012-37
|
(SH Hwang&HJ Cho)PREDICT: a method for inferring novel drug indications with application to personalized medicine
|
2012-36
|
(SH Hwang&HJ Cho)Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype
|
2012-35
|
(JH Shin&HJ Kim)Detecting Novel Associations in Large Data Sets
|
2012/03/05
|
2012-34
|
(8,HH Kim)Mapping and quantifying mammalian transcriptomes by RNA-Seq.
|
2012-33
|
(11,Go&Ju)Differential expression analysis for sequence count data
|
2012-32
|
(12,Go&Ju)edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
|
2012/02/27 2012/02/28
|
2012-31
|
(1,JW Song)RNA-Seq: a revolutionary tool for transcriptomics
|
2012-30
|
(2,JW Song)Computational methods for transcriptome annotation and quantification using RNA-seq
|
2012-29
|
(3,HJ Han)From RNA-seq reads to differential expression results
|
2012-28
|
(4,AR Cho)Comprehensive comparative analysis of strand-specific RNA sequencing methods
|
2012-27
|
(5,T Lee)A Low-Cost Library Construction Protocol and Data Analysis Pipeline for Illumina-Based Strand-Specific Multiplex RNA-Seq
|
2012-26
|
(6,So&Shin)Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
|
2012-25
|
(7,So&Shin)TopHat: discovering splice junctions with RNA-Seq
|
2012/02/06
|
2012-24
|
mirConnX: condition-specific mRNA-microRNA network integrator
|
2012-23
|
Construction and Analysis of an Integrated Regulatory Network Derived from High-Throughput Sequencing Data
|
2012-22
|
A Densely Interconnected Genome-Wide Network of MicroRNAs and Oncogenic Pathways Revealed Using Gene Expression Signatures
|
2012-21
|
Reprogramming of miRNA networks in cancer and leukemia
|
2012-20
|
An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma
|
2012/01/30
|
2012-19
|
Principles and Strategies for Developing Network Models in Cancer
|
2012-18
|
Reverse engineering of regulatory networks in human B cells
|
2012-17
|
Variations in DNA elucidate molecular networks that cause disease
|
2012-16
|
Harnessing gene expression to identify the genetic basis of drug resistance
|
2012-15
|
An Integrated Approach to Uncover Drivers of Cancer
|
2012/01/09
|
2012-14
|
Genetic variation in an individual human exome.
|
2012-13
|
Predicting phenotypic variation in yeast from individual genome sequences.
|
2012-12
|
Clinical assessment incorporating a personal genome.
|
2012/01/09 2012/01/16
|
2012-11
|
Human allelic variation: perspective from protein function, structure, and evolution.
|
2012-10
|
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm.
|
2012-09
|
Prediction of deleterious human alleles.
|
2012-08
|
Human non-synonymous SNPs: server and survey.
|
2012-07
|
A method and server for predicting damaging missense mutations.
|
2012-06
|
SNAP: predict effect of non-synonymous polymorphisms on function
|
2012/01/09 2012/01/16
|
2012-05
|
Computational and statistical approaches to analyzing variants identified by exome sequencing.
|
2012-04
|
Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms.
|
2012-03
|
Targeted capture and massively parallel sequencing of 12 human exomes.
|
2012/01/09 2012/01/16
|
2012-02
|
The distribution of fitness effects of new mutations.
|
2012-01
|
Most Rare Missense Alleles Are Deleterious in Humans: Implications for Complex Disease and Association Studies
|